# Mastec Inc: overview

MTZ · NYSE · CIK 15615 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtz.md) · [Financials](/companies/mtz/financials.md) · [Filings](/companies/mtz/filings.md) · [Insiders](/companies/mtz/insiders.md)

Latest reported revenue: [$5.15bn](/filings/0000015615-26-000125.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0000015615-26-000125).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,403 d](/filings/0000015615-26-000020.md) | [2,848](/filings/0000015615-26-000050.md) | [3,545](/filings/0000015615-26-000093.md) | [3,967](/filings/0000015615-26-000125.md) | [3,940 d](/filings/0000015615-26-000020.md) | [3,829](/filings/0000015615-26-000050.md) | [4,374](/filings/0000015615-26-000093.md) | [5,152](/filings/0000015615-26-000125.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | [1.3%](/filings/0000015615-26-000050.md) | [4.5%](/filings/0000015615-26-000093.md) | [6.3%](/filings/0000015615-26-000125.md) | not reported | [3.7%](/filings/0000015615-26-000050.md) | [5.2%](/filings/0000015615-26-000093.md) | [5.3%](/filings/0000015615-26-000125.md) |
| Net margin | % | [2.2% d](/filings/0000015615-26-000020.md) | [0.3%](/filings/0000015615-26-000050.md) | [2.4%](/filings/0000015615-26-000093.md) | [4.0%](/filings/0000015615-26-000125.md) | [3.6% d](/filings/0000015615-26-000020.md) | [1.6%](/filings/0000015615-26-000050.md) | [3.0%](/filings/0000015615-26-000093.md) | [2.9%](/filings/0000015615-26-000125.md) |
| Diluted EPS | $ per share | not reported | [0.13](/filings/0000015615-26-000050.md) | [1.09](/filings/0000015615-26-000093.md) | [2.04](/filings/0000015615-26-000125.md) | not reported | [0.77](/filings/0000015615-26-000050.md) | [1.65](/filings/0000015615-26-000093.md) | [1.89](/filings/0000015615-26-000125.md) |
| Free cash flow | $m | [423 d](/filings/0000015615-26-000020.md) | [31.1](/filings/0000015615-26-000050.md) | [(58.2) d](/filings/0000015615-26-000093.md) | [20.3 d](/filings/0000015615-26-000125.md) | [293 d](/filings/0000015615-26-000020.md) | [2.1](/filings/0000015615-26-000050.md) | [(70.1) d](/filings/0000015615-26-000093.md) | [180 d](/filings/0000015615-26-000125.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.0](/filings/0000015615-24-000021.md) | [9.8](/filings/0000015615-25-000021.md) | [12.0](/filings/0000015615-26-000020.md) | [12.3](/filings/0000015615-26-000020.md) | [14.3](/filings/0000015615-26-000020.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [4.1%](/filings/0000015615-24-000021.md) | [0.3%](/filings/0000015615-25-000021.md) | [(0.4%)](/filings/0000015615-26-000020.md) | [1.3%](/filings/0000015615-26-000020.md) | [2.8%](/filings/0000015615-26-000020.md) |
| Diluted EPS | $ per share | [4.45](/filings/0000015615-24-000021.md) | [0.42](/filings/0000015615-25-000021.md) | [(0.64)](/filings/0000015615-26-000020.md) | [2.06](/filings/0000015615-26-000020.md) | [5.07](/filings/0000015615-26-000020.md) |
| Free cash flow | $bn | [0.6](/filings/0000015615-24-000021.md) | [0.1](/filings/0000015615-25-000021.md) | [0.5](/filings/0000015615-26-000020.md) | [1.0](/filings/0000015615-26-000020.md) | [0.3](/filings/0000015615-26-000020.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mtz/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.18bn | 7,638,487 |  | Added +328,878 |
| [PECONIC PARTNERS LLC](/funds/1050464.md) | 2026-06-30 | $1.53bn | 3,678,431 |  | Added +100,000 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.18bn | 2,831,849 |  | Added +27,554 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.17bn | 2,812,131 |  | Added +42,093 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $934.0m | 2,244,771 |  | Added +374,983 |
| [Hill City Capital, LP](/funds/1837343.md) | 2026-06-30 | $896.6m | 2,155,000 |  | Unchanged |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $566.8m | 1,318,161 |  | Added +1,116,159 |
| [LONE PINE CAPITAL LLC](/funds/1061165.md) | 2026-06-30 | $559.7m | 1,345,157 |  | Reduced −185,893 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $555.8m | 1,335,924 |  | Added +5,858 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $552.7m | 1,328,399 |  | Reduced −83,185 |

## Recent filings

[All 1,271 filings](/companies/mtz/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:49 ET | [8-K](/filings/0000015615-26-000127.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000015615-26-000127 |
| 2026-10-29 | 16:45 ET | [10-Q](/filings/0000015615-26-000125.md) | Quarterly report, period 2026-09-30 | 0000015615-26-000125 |
| 2026-08-17 | 16:24 ET | [8-K](/filings/0001193125-26-354111.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-354111 |
| 2026-08-13 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-349228.md) | Ownership report, active investor, amended | 0001193125-26-349228 |
| 2026-08-13 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-349231.md) | Ownership report, active investor, amended | 0001193125-26-349231 |
| 2026-08-10 | 16:32 ET | [8-K](/filings/0001193125-26-342507.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342507 |
| 2026-07-31 | 17:11 ET | [8-K](/filings/0001193125-26-328848.md) | 9.01 Financial statements and exhibits | 0001193125-26-328848 |
| 2026-07-30 | 16:28 ET | [8-K](/filings/0000015615-26-000095.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000015615-26-000095 |
| 2026-07-30 | 16:25 ET | [10-Q](/filings/0000015615-26-000093.md) | Quarterly report, period 2026-06-30 | 0000015615-26-000093 |
| 2026-07-20 | 17:16 ET | [8-K](/filings/0001193125-26-309077.md) | 2.03 New direct financial obligation | 0001193125-26-309077 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000015615-26-000020.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/507c0be5-119c-4ebb-94a2-f253cd80426d)

## About the filer

- CIK: 15615
- Tickers: MTZ
- Exchange: NYSE
- SIC code: 1623 Water, Sewer, Pipeline, Comm & Power Line Construction
- State of incorporation: FL
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 19:10 ET. No prices; not investment advice.